Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index; 11 of the 26 sources its claims cite were checked for support.

Clinical features and prognostic factors in adults with viral meningitis.

Open access
Petersen, Pelle Trier, Bodilsen, Jacob, Jepsen, Micha Phill Grønholm, Larsen, Lykke, Storgaard, Merete, Hansen, Birgitte Rønde, Helweg-Larsen, Jannik, Wiese, Lothar, Lüttichau, Hans Rudolf, Andersen, Christian Østergaard, Nielsen, Henrik, Brandt, Christian Thomas, for the Danish Study Group of Infections of the Brain (DASGIB) · 2023 · Brain

Abstract

Clinical features applicable to the entire spectrum of viral meningitis are limited, and prognostic factors for adverse outcomes are undetermined. This nationwide population-based prospective cohort study included all adults with presumed and microbiologically confirmed viral meningitis in Denmark from 2015 until 2020. Prognostic factors for an unfavourable outcome (Glasgow Outcome Scale score of 1-4) 30 days after discharge were examined by modified Poisson regression. In total, 1066 episodes of viral meningitis were included, yielding a mean annual incidence of 4.7 episodes per 100 000 persons. Pathogens were enteroviruses in 419/1066 (39%), herpes simplex virus type 2 in 171/1066 (16%), varicella-zoster virus in 162/1066 (15%), miscellaneous viruses in 31/1066 (3%) and remained unidentified in 283/1066 (27%). The median age was 33 years (IQR 27-44), and 576/1066 (54%) were females. In herpes simplex virus type 2 meningitis, 131/171 (77%) were females. Immunosuppression [32/162 (20%)] and shingles [90/149 (60%)] were frequent in varicella-zoster virus meningitis. The triad of headache, neck stiffness and hyperacusis or photophobia was present in 264/960 (28%). The median time until lumbar puncture was 3.0 h (IQR 1.3-7.1), and the median CSF leucocyte count was 160 cells/µl (IQR 60-358). The outcome was unfavourable in 216/1055 (20%) 30 days after discharge. Using unidentified pathogen as the reference, the adjusted relative risk of an unfavourable outcome was 1.34 (95% CI 0.95-1.88) for enteroviruses, 1.55 (95% CI 1.00-2.41) for herpes simplex virus type 2, 1.51 (95% CI 0.98-2.33) for varicella-zoster virus and 1.37 (95% CI 0.61-3.05) for miscellaneous viruses. The adjusted relative risk of an unfavourable outcome was 1.34 (95% CI 1.03-1.75) for females. Timing of acyclovir or valacyclovir was not associated with the outcome in meningitis caused by herpes simplex virus type 2 or varicella-zoster virus. In summary, the outcome of viral meningitis was similar among patients with different aetiologies, including those with presumed viral meningitis but without an identified pathogen. Females had an increased risk of an unfavourable outcome. Early antiviral treatment was not associated with an improved outcome in meningitis caused by herpes simplex virus type 2 or varicella-zoster virus.

Overview

CoChat Summary

## TL;DR

This nationwide Danish prospective cohort study of 1,066 adult viral meningitis episodes found that outcomes were broadly similar across etiologies, including cases with no identified pathogen. Female sex was associated with a higher risk of an unfavourable 30-day outcome, while earlier acyclovir/valacyclovir was not associated with better outcomes in HSV-2 or VZV meningitis.

## Key findings

  • The study included 1,066 episodes in 1,045 adults; pathogens were enteroviruses 419/1,066 (39%), HSV-2 171/1,066 (16%), VZV 162/1,066 (15%), miscellaneous viruses 31/1,066 (3%), and unidentified 283/1,066 (27%).
  • The mean annual incidence of presumed and microbiologically confirmed viral meningitis was 4.7 episodes per 100,000 persons.
  • An unfavourable outcome at 30 days occurred in 216/1,055 (20%) episodes; by 180 days, it was 62/957 (6%).
  • Compared with meningitis without an identified pathogen, adjusted relative risks for an unfavourable 30-day outcome were 1.34 for enteroviruses, 1.55 for HSV-2, 1.51 for VZV, and 1.37 for miscellaneous viruses; female sex had adjusted RR 1.34 overall.
  • In HSV-2/VZV meningitis, timing of acyclovir or valacyclovir was not associated with outcome: adjusted RR 0.61 for treatment at 8–16 h and 0.86 for ≥17 h versus ≤8 h.

## Methods

  • Nationwide population-based prospective observational cohort using the Danish Study Group of Infections of the Brain (DASGIB) database; adults ≥18 years hospitalized in Denmark between 1 January 2015 and 31 December 2019.
  • Viral meningitis was defined clinically plus CSF/virologic criteria, and the study excluded encephalitis and herpes zoster oticus.
  • Main analysis used modified Poisson regression to estimate crude and adjusted relative risks for unfavourable outcome (GOS 1–4) at 30 days after discharge; additional analyses examined associations with time to lumbar puncture and timing of antiviral treatment.

## Limitations

  • The paper states that some patients might have been admitted elsewhere, which could underestimate incidence and introduce selection bias.
  • The CSF leucocyte cutoff (>10 cells/µl) for presumed meningitis may limit generalizability to patients with lower CSF leucocyte counts.
  • The Glasgow Outcome Scale was not validated for CNS infections and may be too crude to capture subtle neurocognitive impairment; this is stated in the paper.
  • Evident from the text: some outcome data were missing, and some GOS scores were carried forward, which could introduce bias, although the authors report that prognostic results were overall consistent in a restricted analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/brain/awad089

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Aetiologies of viral meningitis in adults.
Figure 1 Aetiologies of viral meningitis in adults.CC BY-NC · PubMed Central
Figure 2 Annual incidences of viral meningitis in adults.
Figure 2 Annual incidences of viral meningitis in adults.CC BY-NC · PubMed Central
Figure 3 Stratified analyses of sex-based differences in unfavourable outcome (GOS score 1–4) 30 days after discharge in adults with viral meningitis. aStratified analyses were adjusted for age (18–30, 31–50, ≥51 years), sex (male, female), immunosuppression (yes, no), triad of headache, neck stiffness and hyperacusis or photophobia (yes, no), CSF leucocyte count (0–100, 101–500, ≥501 cells/µl), CSF protein (0.0–0.5, 0.6–1.0, ≥1.1 g/l), and treatment with dexamethasone for bacterial meningitis (yes, no). The number of episodes used in adjusted analyses were 251 in unidentified pathogen, 369 in EVs, 140 in HSV-2, 140 in VZV and 922 in all viral meningitis.
Figure 3 Stratified analyses of sex-based differences in unfavourable outcome (GOS score 1–4) 30 days after discharge in adults with viral meningitis. aStratified analyses were adjusted for age (18–30, 31–50, ≥51 years), sex (male, female), immunosuppression (yes, no), triad of headache, neck stiffness and hyperacusis or photophobia (yes, no), CSF leucocyte count (0–100, 101–500, ≥501 cells/µl), CSF protein (0.0–0.5, 0.6–1.0, ≥1.1 g/l), and treatment with dexamethasone for bacterial meningitis (yes, no). The number of episodes used in adjusted analyses were 251 in unidentified pathogen, 369 in EVs, 140 in HSV-2, 140 in VZV and 922 in all viral meningitis.CC BY-NC · PubMed Central

Verification

Claims the paper makes

9 Valid · 0 Not valid · 6 Not checked · 56 Own results and interpretations

46 more claims

Create a free account to see all 71 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 13
  • It may state two separate claims as one. 6
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 36 references

Cited by

See all 44

Metadata

Authors
Petersen, P. T., Bodilsen, J., Jepsen, M. P. G., Larsen, L., Storgaard, M., Hansen, B. R., Helweg-Larsen, J., Wiese, L., Lüttichau, H. R., Andersen, C. Ø., Nielsen, H., Brandt, C. T., & for the Danish Study Group of Infections of the Brain (DASGIB)
Affiliations
  • University of Copenhagen (DK)
  • Aalborg University Hospital (DK)
  • Nordsjællands Hospital (DK)
  • Odense University Hospital (DK)
  • Aarhus University Hospital (DK)
  • Hvidovre Hospital (DK)
  • Department of Infectious Diseases, Rigshospitalet , 2100 Copenhagen , Denmark
  • Zealand University Hospital (DK)
  • Herlev Hospital (DK)
Corresponding author
Petersen, Pelle Trier
Venue
Brain
Published
2023-03-16
Volume
146
Issue
9
Pages
3816-3825
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W4327681634
Cited by
44
References
36
Citations by year
2026: 11 · 2025: 14 · 2024: 15 · 2023: 4
FWCI
8.75
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • VBN Forskningsportal (Aalborg Universitet) (publishedVersion, cc-by-nc)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-nc)
Funders
  • Helsefonden (21-B-0437)
  • Helen Rudes Fond (60988)
  • A & J C Tvergaards Fond
  • Minister Erna Hamiltons Legat for Videnskab og Kunst (24-2022)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords
viral meningitis, prognostic factors, clinical features, enterovirus meningitis, immunosuppression, herpes zoster, lumbar puncture timing, hyperacusis, photophobia, neck stiffness, incidence, adults, Denmark
MeSH terms
Adult, Female, Humans, Male, Meningitis, Viral, Prognosis, Prospective Studies, Herpesvirus 3, Human

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical features and prognostic factors in adults with viral meningitis. https://app.cochat.ai/papers/10.1093/brain/awad089
The paper
Petersen, P. T., Bodilsen, J., Jepsen, M. P. G., Larsen, L., Storgaard, M., Hansen, B. R., Helweg-Larsen, J., Wiese, L., Lüttichau, H. R., Andersen, C. Ø., Nielsen, H., Brandt, C. T., & for the Danish Study Group of Infections of the Brain (DASGIB). (2023). Clinical features and prognostic factors in adults with viral meningitis. Brain. https://doi.org/10.1093/brain/awad089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.